Marker Therapeutics (MRKR) Capital Expenditures (2018 - 2023)
Marker Therapeutics (MRKR) posted Capital Expenditures of $2.23 million for Q4 2020, up 15.7% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Capital Expenditures (2018 - 2023) Analysis & Trends
For FY2020, Marker Therapeutics' Capital Expenditures came in at $6.79 million.
- In prior years, Marker Therapeutics' Capital Expenditures was $147,668 in FY2018.
- Quarterly Capital Expenditures has run from a low of -$223,126 in Q2 2019 to a high of $2.53 million in Q2 2020 over five years.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $1.93 million (Q3 2020), $2.53 million (Q2 2020) and $99,821 (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.78 Bn | 1,098.36 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 635.44 Bn | 555.30 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 505.13 Bn | 478.24 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 358.57 Bn | 312.95 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 290.63 Bn | 254.62 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 265.17 Bn | 238.86 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.97 Bn | 193.37 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.50 Bn | 118.15 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Marker Therapeutics | 19.10 Mn | -40.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 112,608.00 |
| Dec 31, 2022 | 127,342.00 |
| Sep 30, 2022 | 99,366.00 |
| Jun 30, 2022 | 2.27 Mn |
| Mar 31, 2022 | 2.45 Mn |
| Dec 31, 2021 | 349,843.00 |
| Sep 30, 2021 | 980,275.00 |
| Jun 30, 2021 | 399,771.00 |
| Mar 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 4.10 Mn |
| Sep 30, 2020 | 1.22 Mn |
| Jun 30, 2020 | 3.83 Mn |
| Mar 31, 2020 | 99,821.00 |
| Dec 31, 2019 | 12,862.00 |
| Sep 30, 2019 | 56,739.00 |
| Jun 30, 2019 | 82,256.00 |
| Mar 31, 2019 | 223,126.00 |
| Dec 31, 2018 | 147,668.00 |
API Access
Marker Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();